Abstract
SpaI is a small lipoprotein that provides Bacillus subtilis with autoimmunity against the lantibiotic subtilin. We have investigated the maturation of SpaI through the lipoprotein biosynthesis pathway, and analyzed the consequences of maturations in the acylation of the target lipobox in subtilin immunity. Further specificity of lipid acylation of the cysteine within the conserved sequence of the candidate lipobox (LSAC) was studied by site-directed mutagenesis. The mutants LSAA and LSCA blocked lipid attachment to the SpaI protein. Cell-wall stress-sensing B. subtilis BSF 2470 was exploited to study the function of each mutant upon heterologous expression. This system allowed the monitoring of beta-galactosidase activity to the added subtilin at a sublethal dose. Mutants exhibited 2-fold reduction in beta-Gal activity, suggesting their contribution in subtilin autoimmunity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
